Clinical impact of interstitial pneumonia following surgery for lung cancer: Serum KL-6 is an indicator?

Thoracic and Cardiovascular Surgeon

Volumn 54, Issue 4, 2006, Pages 268-272

  Takeda, S ^a   Maeda, H ^a   Sawabata, N ^a   Kitada, S ^a   Mori, M ^a   Takashima, S ^a   Matsubara, Y ^a   Takeda, Shin Ichi ^a  

^a TONEYAMA NATIONAL HOSPITAL   (Japan)

Author keywords

Acute interstitial pneumonia; Adult respiratory distress syndrome (ARDS); Interstitial pneumonia; Lung cancer

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG CANCER; LUNG FUNCTION; LUNG LOBECTOMY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HOSPITAL MORTALITY; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUCIN-1; MUCINS; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; THORACOTOMY;

EID: 33745312968     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-873068     Document Type: Article

References (25)

1. Kutlu CA, Williams EA, Evans TW, Pastorino U, Goldstraw P. Acute lung injury and acute respiratory syndrome after pulmonary resection. Ann Thorac Surg 2000; 69: 376-380
2. Wada H, Nakamura T, Nakamoto K, Maeda M, Watanabe Y. Thirty day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg 1998; 115: 70-73
3. Tanita T, Chida M, Hoshikawa Y et al. Experience with fetal interstitial pneumonia after operation for lung cancer. J Cardiovasc Surg 2001; 42: 125-129
4. Watanabe S, Asamura H, Suzuki K, Tsuchiya R. Recent results of post-operative mortality for surgical resections in lung cancer. Ann Thorac Surg 2004; 78: 999-1003
5. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. New Engl J Med 2001; 345: 517-525
6. Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000; 162: 2213-2217
7. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 2000; 161: 5-8
8. Matsushita H, Tanaka S, Saiki Y et al. Lung cancer associated with usual interstitial pneumonia. Pathol Int 1995; 45: 925-932
9. Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K. Acute exerbation in idiopathic pulmonary fibrosis: Analysis of clinical and pathologic findings in three cases. Chest 1993; 103: 1808-1812
10. Kumar P, Goldstraw P, Yamada K et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg 2003; 125: 1321-1327
11. Chiyo M, Sekine Y, Iwata T et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg 2003; 126: 1141-1146
12. Fujimoto T, Okazaki T, Matsukura T et al. Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? Ann Thorac Surg 2003; 76: 1674-1679
13. Martinod E, Azorin JF, Sadoun D et al. Surgical resection of lung cancer in patients with underlying interstitial lung disease. Ann Thorac Surg 2002; 74: 1004-1007
14. Bouros D, Nicholson AC, Polychronopoulos V, du Bois RM. Acute interstitial pneumonia. Eur Respir J 2000; 15: 412-418
15. Goto K, Kodama T, Sekine I et al. Serum levels of KL-6 are useful biomarkers for severe radiation pneumonitis. Lung Cancer 2001; 34: 141-148
16. Nakahara K, Monden Y, Ohno K, Maeda H, Kawashima Y. A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer. Ann Thorac Surg 1985;39:260-265
17. King TE, Costabel U, Cordier JF et al. Idiopathic pulmonary diagnosis and treatment: International consensus statement. Am J Respir Crit Care Med 2000; 161: 646-664
18. Katzenstein AA, Myers JL. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: 1301-1315
19. Kobayashi J, Kitamura S. KL-6: A serum marker for interstitial pneumonia. Chest 1995; 108: 311-315
20. Sakuma T, Takahashi K, Ohya N, Usuda K, Handa M. Serum KL-6, a novel mucin-like glycoprotein, as a indicator of intersitial pneumonitis following lobectomy. Surg Today 1999; 29: 121-128
21. Greene KE, King Jr TE, Kuroki Y et al. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J 2002; 19: 439-446
22. Daniil ZD, Gilchrist FC, Nicholson AG et al. A histologic pattern of non-specific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999; 160: 899-905
23. Kawasaki H, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol 2002; 81: 33-37
24. Sato H, Callister MEJ, Mumby S et al. KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome. Eur Respir J 2004; 23: 142-145
25. Yaekashiwa M, Nakayama S, Ohnuma K et al. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med 1997; 156: 1937-1944